To determine the mitochondrial mutational landscape in prostate cancer, Hopkins et al. analyzed 384 patients and observed changes in the heteroplasmy levels of MT-CO1 mutations, for instance, the 6419A allele, which was heteroplasmic within the normal samples but homoplasmic in the tumor [23]. The gene discussed is MT-CO1; the disease is prostate cancer.